The makers of the leading COVID-19 vaccines in the U.S. all said Wednesday they have new data showing that an extra shot of their vaccine can boost protection significantly. After Pfizer, the remaining could receive full FDA approval as early as next month. But as officials prepare for adult boosters, plans to vaccinate kids of all ages with their first shot are lagging. William Brangham explores.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts